Agency Forms Undergoing Paperwork Reduction Act Review, 43985-43988 [2017-20009]
Download as PDF
<![CDATA[
43985
Federal Register / Vol. 82, No. 181 / Wednesday, September 20, 2017 / Notices
well as focus groups and interviews. For
each population, we will collect data
from (1) families (i.e., parents/caregivers
of children and adolescents, as well as
adolescents themselves) with special
health care needs and ASD; and (2) the
medical, social service and other
providers who serve them. In addition,
we will collect data from emergencyresponse agency representatives and
experts in health information and
communications technology to ask
cross-cutting questions regarding the
use of technology to communicate
during disasters, and the perspectives
in the collection of data or otherwise
have contact with the participants.
Drexel will store all the data, and CDC
will only receive coded and aggregated
data so it will not be possible to link
responses with individual subjects. Data
will be treated in a secure manner and
will not be disclosed, unless otherwise
compelled by law.
The total estimated annualized time
burden to respondents is 419 hours.
This information collection request is
a new request and approval is requested
for 24 months.
and needs of individuals and agencies
charged with leading disaster response
efforts.
The data resulting from this study
will be used to develop specific tools,
protocols, and message templates that
can be used for communicating during
emergencies and disasters with families
with CYSHCN and ASD.
CDC plans to begin the information
collection one month after OMB
approval and continue for twenty two
months. Information in identifiable form
will not be linked to interview
responses. No CDC staff will participate
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
hours
Type of respondent
Form name
Families/Caregivers (CYSHCN) ........................
Families/Caregivers (ASD) ................................
Providers (CYSHCN) .........................................
Providers (ASD) .................................................
Families/Caregivers (CYSHCN) ........................
Families/Caregivers (ASD) ................................
Families/Caregivers (CYSHCN and ASD) ........
150
200
250
150
50
30
30
1
1
1
1
1
1
1
15/60
15/60
15/60
15/60
1
1
1.5
38
50
63
38
50
30
45
Providers (CYSHCN) .........................................
Providers (ASD) .................................................
Emergency Response Organizations ................
Health IT Professionals .....................................
Providers ............................................................
CYSHCN Family/Caregiver Survey ..................
ASD Family/Caregiver Survey ..........................
CYSHCN Provider Survey ................................
ASD Provider Survey ........................................
CYSHCN Family/Caregiver Interviews .............
ASD Family/Caregiver Interviews .....................
CYSHCN & ASD Family/Caregiver Evaluation
Focus Group.
CYSHCN Provider Focus Group ......................
ASD Provider Focus Group ..............................
Emergency Response Focus Group ................
Health IT Focus Group .....................................
Provider Evaluation Focus Group .....................
20
10
10
10
20
1
1
1
1
1
1.5
1.5
1.5
1.5
1.5
30
15
15
15
30
Total ............................................................
...........................................................................
........................
........................
........................
419
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–19959 Filed 9–19–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–0666]
sradovich on DSKBBY8HB2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on May 30,
2017 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
first notice. The purpose of this notice
VerDate Sep<11>2014
18:28 Sep 19, 2017
Jkt 241001
is to allow an additional 30 days for
public comments.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. The Office
of Management and Budget is
particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW.,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
National Healthcare Safety Network
(NHSN) (OMB No. 0920–0666), exp.
11/30/2019—Revision—National Center
for Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Healthcare Safety
Network (NHSN) is a system designed to
accumulate, exchange, and integrate
relevant information and resources
among private and public stakeholders
to support local and national efforts to
protect patients and promote healthcare
safety. Specifically, CDC uses the data to
E:\FR\FM\20SEN1.SGM
20SEN1
43986
Federal Register / Vol. 82, No. 181 / Wednesday, September 20, 2017 / Notices
determine the magnitude of various
healthcare-associated adverse events
and trends in the rates of these events
among patients and healthcare workers
with similar risks. CDC will use the data
to detect changes in the epidemiology of
adverse events resulting from new and
current medical therapies and changing
risks.
The NHSN currently consists of five
components: Patient Safety, Healthcare
Personnel Safety, Biovigilance, LongTerm Care Facility (LTCF), and Dialysis.
CDC will release the NHSN ‘‘Outpatient
Procedure Component’’ in 2018. CDC’s
request for additional user feedback and
support from outside partners delayed
development of this component.
After receiving user feedback and
internal review feedback, CDC made
changes to six facility surveys. For the
annual facility surveys, CDC amended,
removed, or added questions and
response options to fit the survey’s
evolving uses. In addition, CDC and its
partners use the surveys to help
intelligently interpret the other data
elements reported into NHSN.
Currently, the surveys are used to
appropriately risk adjust the numerator
and denominator data entered into
NHSN while also guiding decisions on
future division priorities for prevention.
Further, two new forms were added to
expand NHSN surveillance to enhance
data collection by Ambulatory Surgical
Centers to identify areas where
prevention of SSIs may be improved.
CDC modified an additional 14 forms
within the Hemovigilance module to
streamline data collection/entry for
adverse reaction events.
Overall, CDC has made minor
revisions to a total of 44 forms within
the package to clarify and/or update
surveillance definitions, increase or
decrease the number of reporting
facilities, and adding 2 new forms. The
previously approved NHSN information
collection package included 70
individual collection forms; the current
revision request includes 72 forms. The
reporting burden will increase by
811,985 hours, for a total of 5,922,953
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Staff RN ...............................
Staff RN ...............................
Staff RN ...............................
Registered Nurse (Infection
Preventionist).
Staff RN ...............................
Laboratory Technician .........
sradovich on DSKBBY8HB2PROD with NOTICES
Pharmacist ...........................
Registered Nurse
Preventionist).
Registered Nurse
Preventionist).
Registered Nurse
Preventionist).
Registered Nurse
Preventionist).
Registered Nurse
Preventionist).
Registered Nurse
Preventionist).
VerDate Sep<11>2014
(Infection
(Infection
(Infection
Number of
respondents
Form No. & name
Number of
responses per
respondent
Average
burden per
response
(hours)
57.100
NHSN Registration Form ............................................
2,000
1
5/60
57.101
Facility Contact Information ........................................
2,000
1
10/60
57.103
Patient Safety Component—Annual Hospital Survey
5,000
1
55/60
57.105
Group Contact Information .........................................
1,000
1
5/60
57.106
Patient Safety Monthly Reporting Plan ......................
6,000
12
15/60
57.108
Primary Bloodstream Infection (BSI) ..........................
6,000
44
30/60
57.111
Pneumonia (PNEU) ....................................................
6,000
72
30/60
57.112
Ventilator-Associated Event .......................................
6,000
144
25/60
57.113
Pediatric Ventilator-Associated Event (PedVAE) .......
2,000
120
25/60
57.114
Urinary Tract Infection (UTI) .......................................
6,000
40
20/60
57.115
Custom Event .............................................................
2,000
91
35/60
57.116 Denominators for Neonatal Intensive Care Unit
(NICU).
57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC).
57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA).
57.120 Surgical Site Infection (SSI) .......................................
6,000
12
4
6,000
9
5
6,000
60
5
6,000
36
35/60
6,000
6,000
540
12
10/60
5/60
6,000
12
5/60
100
100
25/60
6,000
72
30/60
6,000
24
15/60
6,000
240
20/60
57.121 Denominator for Procedure ........................................
57.123 Antimicrobial Use and Resistance (AUR)—Microbiology Data Electronic Upload Specification Tables.
57.124 Antimicrobial Use and Resistance (AUR)—Pharmacy
Data Electronic Upload Specification Tables.
57.125 Central Line Insertion Practices Adherence Monitoring.
57.126 MDRO or CDI Infection Form .....................................
(Infection
57.127 MDRO and CDI Prevention Process and Outcome
Measures Monthly Monitoring.
57.128 Laboratory-identified MDRO or CDI Event .................
(Infection
57.129
Adult Sepsis ................................................................
50
250
25/60
(Infection
57.137 Long-Term Care Facility Component—Annual Facility Survey.
2,600
1
2
18:28 Sep 19, 2017
Jkt 241001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\20SEN1.SGM
20SEN1
43987
Federal Register / Vol. 82, No. 181 / Wednesday, September 20, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
sradovich on DSKBBY8HB2PROD with NOTICES
Type of respondent
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Registered Nurse (Infection
Preventionist).
Occupational Health RN/
Specialist.
Occupational Health RN/
Specialist.
Occupational Health RN/
Specialist.
Occupational Health RN/
Specialist.
Occupational Health RN/
Specialist.
Laboratory Technician .........
Occupational Health RN/
Specialist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
Medical/Clinical Laboratory
Technologist.
VerDate Sep<11>2014
18:28 Sep 19, 2017
Number of
respondents
Form No. & name
57.138
Laboratory-identified MDRO or CDI Event for LTCF
Number of
responses per
respondent
Average
burden per
response
(hours)
2,600
12
15/60
57.139 MDRO and CDI Prevention Process Measures
Monthly Monitoring for LTCF.
57.140 Urinary Tract Infection (UTI) for LTCF .......................
2,600
12
10/60
2,600
14
30/60
57.141
Monthly Reporting Plan for LTCF ..............................
2,600
12
5/60
57.142
Denominators for LTCF Locations .............................
2,600
12
4
57.143 Prevention Process Measures Monthly Monitoring
for LTCF.
57.150 LTAC Annual Survey ..................................................
2,600
12
5/60
400
1
55/60
57.151
Rehab Annual Survey ................................................
1,000
1
55/60
57.200 Healthcare Personnel Safety Component Annual Facility Survey.
57.203 Healthcare Personnel Safety Monthly Reporting Plan
50
1
8
17,000
1
5/60
57.204
Healthcare Worker Demographic Data ......................
50
200
20/60
57.205
Exposure to Blood/Body Fluids ..................................
50
50
1
57.206
Healthcare Worker Prophylaxis/Treatment ................
50
30
15/60
57.207 Follow-Up Laboratory Testing ....................................
57.210 Healthcare Worker Prophylaxis/Treatment-Influenza
50
50
50
50
15/60
10/60
57.300
Hemovigilance Module Annual Survey ......................
500
1
2
57.301
Hemovigilance Module Monthly Reporting Plan ........
500
12
1/60
57.303 Hemovigilance Module Monthly Reporting Denominators.
57.305 Hemovigilance Incident ..............................................
500
12
1.17
500
10
10/60
57.306 Hemovigilance Module Annual Survey—Non-acute
care facility.
57.307 Hemovigilance Adverse Reaction—Acute Hemolytic
Transfusion Reaction.
57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction.
57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction.
57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction.
57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction.
57.312 Hemovigilance
Adverse
Reaction—Hypotensive
Transfusion Reaction.
57.313 Hemovigilance Adverse Reaction—Infection .............
200
1
35/60
500
4
20/60
500
4
20/60
500
1
20/60
500
2
20/60
500
4
20/60
500
1
20/60
500
1
20/60
57.314 Hemovigilance Adverse Reaction—Post Transfusion
Purpura.
57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea.
57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease.
57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury.
57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload.
57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction.
57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction.
57.400 Patient Safety Component—Annual Facility Survey ..
500
1
20/60
500
1
20/60
500
1
20/60
500
1
20/60
500
2
20/60
500
1
20/60
500
1
20/60
5,000
1
5/60
Jkt 241001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
E:\FR\FM\20SEN1.SGM
20SEN1
43988
Federal Register / Vol. 82, No. 181 / Wednesday, September 20, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of respondent
Form No. & name
Staff RN ...............................
57.401 Outpatient Procedure Component—Monthly Reporting Plan.
57.402 Outpatient Procedure Component—Same Day Outcome Measures & Prophylactic Intravenous (IV) Antibiotic
Timing Event.
57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures & Prophylactic Intravenous (IV) Antibiotic Timing Event.
57.404 Outpatient Procedure Component—Annual Facility
Survey.
57.405 Outpatient Procedure Component—Surgical Site
(SSI) Event.
57.500 Outpatient Dialysis Center Practices Survey .............
57.501 Dialysis Monthly Reporting Plan ................................
Staff RN ...............................
Staff RN ...............................
Staff RN ...............................
Registered Nurse (Infection
Preventionist).
Staff RN ...............................
Registered Nurse (Infection
Preventionist).
Staff RN ...............................
Staff RN ...............................
Staff RN ...............................
Staff RN ...............................
Staff RN ...............................
Staff RN ...............................
[FR Doc. 2017–20009 Filed 9–19–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–17–0822; Docket No. CDC 2017–
0067]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on The National Intimate
Partner and Sexual Violence Survey
(NISVS) to collect information about
sradovich on DSKBBY8HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:28 Sep 19, 2017
Jkt 241001
individual’s experiences of sexual
violence, stalking and intimate partner
violence and information about the
health consequences of these forms of
violence. CDC produces national and
state level prevalence estimates of these
types of violence.
DATES: Written comments must be
received on or before November 20,
2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0067 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
Please note: All public comment should be
submitted through the Federal eRulemaking
portal Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Leroy Richardson,
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Average
burden per
response
(hours)
5,000
12
15/60
5,000
25
40/60
5,000
12
40/60
5,000
540
10/60
5,000
36
35/60
7,000
7,000
1
12
2.0
5/60
7,000
7,000
2,000
60
12
12
25/60
10/60
1.25
325
325
350
57.502 Dialysis Event .............................................................
57.503 Denominator for Outpatient Dialysis ..........................
57.504 Prevention Process Measures Monthly Monitoring
for Dialysis.
57.505 Dialysis Patient Influenza Vaccination .......................
57.506 Dialysis Patient Influenza Vaccination Denominator ..
57.507 Home Dialysis Center Practices Survey ....................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
Number of
responses per
respondent
75
5
1
10/60
10/60
30/60
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501–3520),
Federal agencies must obtain approval
from the Office of Management and
Budget (OMB) for each collection of
information they conduct or sponsor. In
addition, the PRA also requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each new proposed
collection, each proposed extension of
existing collection of information, and
each reinstatement of previously
approved information collection before
submitting the collection to OMB for
approval. To comply with this
requirement, we are publishing this
notice of a proposed data collection as
described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
E:\FR\FM\20SEN1.SGM
20SEN1
]]>Agencies
[Federal Register Volume 82, Number 181 (Wednesday, September 20, 2017)]
[Notices]
[Pages 43985-43988]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20009]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-0666]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on May 30, 2017 to obtain comments from the
public and affected agencies. CDC received one comment related to the
first notice. The purpose of this notice is to allow an additional 30
days for public comments.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW., Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
National Healthcare Safety Network (NHSN) (OMB No. 0920-0666), exp.
11/30/2019--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Healthcare Safety Network (NHSN) is a system designed
to accumulate, exchange, and integrate relevant information and
resources among private and public stakeholders to support local and
national efforts to protect patients and promote healthcare safety.
Specifically, CDC uses the data to
[[Page 43986]]
determine the magnitude of various healthcare-associated adverse events
and trends in the rates of these events among patients and healthcare
workers with similar risks. CDC will use the data to detect changes in
the epidemiology of adverse events resulting from new and current
medical therapies and changing risks.
The NHSN currently consists of five components: Patient Safety,
Healthcare Personnel Safety, Biovigilance, Long-Term Care Facility
(LTCF), and Dialysis. CDC will release the NHSN ``Outpatient Procedure
Component'' in 2018. CDC's request for additional user feedback and
support from outside partners delayed development of this component.
After receiving user feedback and internal review feedback, CDC
made changes to six facility surveys. For the annual facility surveys,
CDC amended, removed, or added questions and response options to fit
the survey's evolving uses. In addition, CDC and its partners use the
surveys to help intelligently interpret the other data elements
reported into NHSN. Currently, the surveys are used to appropriately
risk adjust the numerator and denominator data entered into NHSN while
also guiding decisions on future division priorities for prevention.
Further, two new forms were added to expand NHSN surveillance to
enhance data collection by Ambulatory Surgical Centers to identify
areas where prevention of SSIs may be improved. CDC modified an
additional 14 forms within the Hemovigilance module to streamline data
collection/entry for adverse reaction events.
Overall, CDC has made minor revisions to a total of 44 forms within
the package to clarify and/or update surveillance definitions, increase
or decrease the number of reporting facilities, and adding 2 new forms.
The previously approved NHSN information collection package included 70
individual collection forms; the current revision request includes 72
forms. The reporting burden will increase by 811,985 hours, for a total
of 5,922,953 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form No. & name Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
Registered Nurse (Infection 57.100 NHSN Registration 2,000 1 5/60
Preventionist). Form.
Registered Nurse (Infection 57.101 Facility Contact 2,000 1 10/60
Preventionist). Information.
Registered Nurse (Infection 57.103 Patient Safety 5,000 1 55/60
Preventionist). Component--Annual
Hospital Survey.
Registered Nurse (Infection 57.105 Group Contact 1,000 1 5/60
Preventionist). Information.
Registered Nurse (Infection 57.106 Patient Safety 6,000 12 15/60
Preventionist). Monthly Reporting Plan.
Registered Nurse (Infection 57.108 Primary 6,000 44 30/60
Preventionist). Bloodstream Infection
(BSI).
Registered Nurse (Infection 57.111 Pneumonia (PNEU). 6,000 72 30/60
Preventionist).
Registered Nurse (Infection 57.112 Ventilator- 6,000 144 25/60
Preventionist). Associated Event.
Registered Nurse (Infection 57.113 Pediatric 2,000 120 25/60
Preventionist). Ventilator-Associated
Event (PedVAE).
Registered Nurse (Infection 57.114 Urinary Tract 6,000 40 20/60
Preventionist). Infection (UTI).
Registered Nurse (Infection 57.115 Custom Event..... 2,000 91 35/60
Preventionist).
Staff RN.............................. 57.116 Denominators for 6,000 12 4
Neonatal Intensive Care
Unit (NICU).
Staff RN.............................. 57.117 Denominators for 6,000 9 5
Specialty Care Area
(SCA)/Oncology (ONC).
Staff RN.............................. 57.118 Denominators for 6,000 60 5
Intensive Care Unit
(ICU)/Other locations
(not NICU or SCA).
Registered Nurse (Infection 57.120 Surgical Site 6,000 36 35/60
Preventionist). Infection (SSI).
Staff RN.............................. 57.121 Denominator for 6,000 540 10/60
Procedure.
Laboratory Technician................. 57.123 Antimicrobial Use 6,000 12 5/60
and Resistance (AUR)--
Microbiology Data
Electronic Upload
Specification Tables.
Pharmacist............................ 57.124 Antimicrobial Use 6,000 12 5/60
and Resistance (AUR)--
Pharmacy Data
Electronic Upload
Specification Tables.
Registered Nurse (Infection 57.125 Central Line 100 100 25/60
Preventionist). Insertion Practices
Adherence Monitoring.
Registered Nurse (Infection 57.126 MDRO or CDI 6,000 72 30/60
Preventionist). Infection Form.
Registered Nurse (Infection 57.127 MDRO and CDI 6,000 24 15/60
Preventionist). Prevention Process and
Outcome Measures
Monthly Monitoring.
Registered Nurse (Infection 57.128 Laboratory- 6,000 240 20/60
Preventionist). identified MDRO or CDI
Event.
Registered Nurse (Infection 57.129 Adult Sepsis..... 50 250 25/60
Preventionist).
Registered Nurse (Infection 57.137 Long-Term Care 2,600 1 2
Preventionist). Facility Component--
Annual Facility Survey.
[[Page 43987]]
Registered Nurse (Infection 57.138 Laboratory- 2,600 12 15/60
Preventionist). identified MDRO or CDI
Event for LTCF.
Registered Nurse (Infection 57.139 MDRO and CDI 2,600 12 10/60
Preventionist). Prevention Process
Measures Monthly
Monitoring for LTCF.
Registered Nurse (Infection 57.140 Urinary Tract 2,600 14 30/60
Preventionist). Infection (UTI) for
LTCF.
Registered Nurse (Infection 57.141 Monthly Reporting 2,600 12 5/60
Preventionist). Plan for LTCF.
Registered Nurse (Infection 57.142 Denominators for 2,600 12 4
Preventionist). LTCF Locations.
Registered Nurse (Infection 57.143 Prevention 2,600 12 5/60
Preventionist). Process Measures
Monthly Monitoring for
LTCF.
Registered Nurse (Infection 57.150 LTAC Annual 400 1 55/60
Preventionist). Survey.
Registered Nurse (Infection 57.151 Rehab Annual 1,000 1 55/60
Preventionist). Survey.
Occupational Health RN/Specialist..... 57.200 Healthcare 50 1 8
Personnel Safety
Component Annual
Facility Survey.
Occupational Health RN/Specialist..... 57.203 Healthcare 17,000 1 5/60
Personnel Safety
Monthly Reporting Plan.
Occupational Health RN/Specialist..... 57.204 Healthcare Worker 50 200 20/60
Demographic Data.
Occupational Health RN/Specialist..... 57.205 Exposure to Blood/ 50 50 1
Body Fluids.
Occupational Health RN/Specialist..... 57.206 Healthcare Worker 50 30 15/60
Prophylaxis/Treatment.
Laboratory Technician................. 57.207 Follow-Up 50 50 15/60
Laboratory Testing.
Occupational Health RN/Specialist..... 57.210 Healthcare Worker 50 50 10/60
Prophylaxis/Treatment-
Influenza.
Medical/Clinical Laboratory 57.300 Hemovigilance 500 1 2
Technologist. Module Annual Survey.
Medical/Clinical Laboratory 57.301 Hemovigilance 500 12 1/60
Technologist. Module Monthly
Reporting Plan.
Medical/Clinical Laboratory 57.303 Hemovigilance 500 12 1.17
Technologist. Module Monthly
Reporting Denominators.
Medical/Clinical Laboratory 57.305 Hemovigilance 500 10 10/60
Technologist. Incident.
Medical/Clinical Laboratory 57.306 Hemovigilance 200 1 35/60
Technologist. Module Annual Survey--
Non-acute care facility.
Medical/Clinical Laboratory 57.307 Hemovigilance 500 4 20/60
Technologist. Adverse Reaction--Acute
Hemolytic Transfusion
Reaction.
Medical/Clinical Laboratory 57.308 Hemovigilance 500 4 20/60
Technologist. Adverse Reaction--
Allergic Transfusion
Reaction.
Medical/Clinical Laboratory 57.309 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--
Delayed Hemolytic
Transfusion Reaction.
Medical/Clinical Laboratory 57.310 Hemovigilance 500 2 20/60
Technologist. Adverse Reaction--
Delayed Serologic
Transfusion Reaction.
Medical/Clinical Laboratory 57.311 Hemovigilance 500 4 20/60
Technologist. Adverse Reaction--
Febrile Non-hemolytic
Transfusion Reaction.
Medical/Clinical Laboratory 57.312 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--
Hypotensive Transfusion
Reaction.
Medical/Clinical Laboratory 57.313 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--
Infection.
Medical/Clinical Laboratory 57.314 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--Post
Transfusion Purpura.
Medical/Clinical Laboratory 57.315 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--
Transfusion Associated
Dyspnea.
Medical/Clinical Laboratory 57.316 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--
Transfusion Associated
Graft vs. Host Disease.
Medical/Clinical Laboratory 57.317 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--
Transfusion Related
Acute Lung Injury.
Medical/Clinical Laboratory 57.318 Hemovigilance 500 2 20/60
Technologist. Adverse Reaction--
Transfusion Associated
Circulatory Overload.
Medical/Clinical Laboratory 57.319 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--
Unknown Transfusion
Reaction.
Medical/Clinical Laboratory 57.320 Hemovigilance 500 1 20/60
Technologist. Adverse Reaction--Other
Transfusion Reaction.
Medical/Clinical Laboratory 57.400 Patient Safety 5,000 1 5/60
Technologist. Component--Annual
Facility Survey.
[[Page 43988]]
Staff RN.............................. 57.401 Outpatient 5,000 12 15/60
Procedure Component--
Monthly Reporting Plan.
Staff RN.............................. 57.402 Outpatient 5,000 25 40/60
Procedure Component--
Same Day Outcome
Measures & Prophylactic
Intravenous (IV)
Antibiotic Timing Event.
Staff RN.............................. 57.403 Outpatient 5,000 12 40/60
Procedure Component--
Monthly Denominators
for Same Day Outcome
Measures & Prophylactic
Intravenous (IV)
Antibiotic Timing Event.
Staff RN.............................. 57.404 Outpatient 5,000 540 10/60
Procedure Component--
Annual Facility Survey.
Registered Nurse (Infection 57.405 Outpatient 5,000 36 35/60
Preventionist). Procedure Component--
Surgical Site (SSI)
Event.
Staff RN.............................. 57.500 Outpatient 7,000 1 2.0
Dialysis Center
Practices Survey.
Registered Nurse (Infection 57.501 Dialysis Monthly 7,000 12 5/60
Preventionist). Reporting Plan.
Staff RN.............................. 57.502 Dialysis Event... 7,000 60 25/60
Staff RN.............................. 57.503 Denominator for 7,000 12 10/60
Outpatient Dialysis.
Staff RN.............................. 57.504 Prevention 2,000 12 1.25
Process Measures
Monthly Monitoring for
Dialysis.
Staff RN.............................. 57.505 Dialysis Patient 325 75 10/60
Influenza Vaccination.
Staff RN.............................. 57.506 Dialysis Patient 325 5 10/60
Influenza Vaccination
Denominator.
Staff RN.............................. 57.507 Home Dialysis 350 1 30/60
Center Practices Survey.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-20009 Filed 9-19-17; 8:45 am]
BILLING CODE 4163-18-P
